Leerink Partners Raises Price Target on Stryker (SYK) to $125 Following 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Becton Dickinson (BDX) Announces Sale of Vertebral Augmentation Solutions Business to Stryker
April 21, 2016 7:35 AM EDTBD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®, AVAflex®, AVAtex® and AVAprep® branded products to Stryker.
This sale will not have a material impact to... More
Stryker (SYK) Tops Q1 EPS by 4c, Boosts FY Gudiance
April 20, 2016 4:10 PM EDTStryker (NYSE: SYK) reported Q1 EPS of $1.24, $0.04 better than the analyst estimate of $1.20. Revenue for the quarter came in at $2.5 billion versus the consensus estimate of $2.47 billion.
GUIDANCE:
Stryker sees Q2 2016 EPS of $1.33-$1.38, versus the consensus of... More
